Kurt Karst is speaking at AAM’s Generic + Biosimilars Conference

Moderator: Approval Pathways for Complex Generics – 505(j) vs. 505(b)(2)

When

November 9, 20121

Contact

For more information see conference website

Professionals
Related Professionals